Skip to main content

Table 3 The 28-day or 90-day LT-free mortality rates in the ACLF patients with serum HBV DNA ad-level lower or higher than 2000 IU/ml or 2 × 106 IU/ml

From: Is HBV viral load at admission associated with development of acute-on-chronic liver failure in patients with acute decompensation of chronic hepatitis B related cirrhosis?

HBV DNA (IU/ml)

28-day prognosis

90-day prognosis

n

mortality, n(%)

n

mortality, n(%)

<2000

13

1 (7.7)

7

3 (42.9)

≥2000

26

5 (19.2)

15

6 (40.0)

<2 × 106

31

4 (12.9)

17

7 (41.2)

≥2 × 106

8

2 (25.0)

5

2 (40.0)

Total

39

6 (15.4)

22

9 (40.9)

  1. 1. LT: liver transplantation
  2. 2. HBV DNA <2000 IU/ml or ≥ 2000 IU/ml: 28-day LT-free mortality rates: Fisher’s exact test, P = 0.643; 90-day LT-free mortality rates: Fisher’s exact test, P = 1.000
  3. 3. HBV DNA <2 × 106 IU/ml or ≥ 2 × 106 IU/ml: 28-day LT-free mortality rates: Fisher’s exact test, P = 0.583; 90-day LT-free mortality rates: Fisher’s exact test, P = 1.000